Summary of Key Points Core Viewpoint - Hendi Pharmaceutical (301211.SZ) announced plans for significant share reductions by major shareholders, indicating potential changes in ownership structure and market sentiment towards the company [1] Group 1: Shareholder Reductions - Shareholder Ningkang Enterprise Management Center (Limited Partnership) plans to reduce its holdings by up to 4,176,000 shares, representing 1% of the total share capital, within three months after the announcement [1] - Shareholder Beikang Enterprise Management Center (Limited Partnership) intends to reduce its holdings by up to 1,392,000 shares, accounting for 0.33% of the total share capital, within the same timeframe [1] - Shareholder Lei Xiaoyan plans to reduce her holdings by up to 4,176,000 shares, also representing 1% of the total share capital, within three months after three trading days from the announcement [1]
亨迪药业：宁康企管拟减持不超过1%股份